Evaluation of spironolactone plus hydrochlorothiazide in reducing proteinuria in type 2 diabetic nephropathy
Conclusion:
Our results showed that spironolactone plus hydrochlorothiazide is an effective and inexpensive modality in the treatment of diabetic nephropathy without increasing serum potassium.
Source: Journal of the Renin-Angiotensin-Aldosterone System : JRAAS - Category: Biomedical Science Authors: Momeni, A., Behradmanesh, M. S., Kheiri, S., Karami Horestani, M. Tags: Original Articles Source Type: research
More News: Biomedical Science | Clinical Trials | Diabetes | Diabetes Type 2 | Endocrinology | Hydrochlorothiazide | Proteinuria | Spironolactone | Study